Health Care without Borders: The Opportunities and Challenges of Medical Tourism

Price: $0 OnDemand


Sign up today for an entire year of unlimited access to relevant, timely professional learning courses, including webinars, eLearning courses and OnDemand offerings, and keep your professional credits up to date. All for just $399.

Learn more about the subscription!


This is a complimentary program sponsored by Manatt, Phelps & Phillips, LLP.

Manatt logo

Once considered a fringe option, medical tourism has gained mainstream acceptance.  According to the Centers for Disease Control, up to 750,000 Americans a year travel abroad for health care.  Projections for the next decade call for U.S. residents to spend more than $300 billion in foreign care, up from less than $2 billion in 2005.

With the globalization of health care, people are increasingly open to looking beyond their backyards for effective and affordable care.  What are the benefits – and the risks – for employers, payers, providers and patients?  Which trends in U.S. health care are driving the desire to seek foreign alternatives?  How does medical tourism really work – and what are the legal issues to consider?  Manatt provides answers in a new webinar, “Health Care without Borders: The Opportunities and Challenges of Medical Tourism.”  Providing new research on American attitudes toward receiving care outside the country, the webinar explores medical tourism from four critical perspectives – financial, clinical, regulatory and consumer readiness.

The session will explore the market dynamics in the U.S. that are making medical tourism an appealing alternative for payers, employers and patients seeking to lower costs.  It will then take a detailed look at medical tourism, including myths vs. facts on a full range of critical attributes from cost to quality, with an emphasis on Mexico, one of the most popular destination for U.S. patients.  This segment will include an inside look at how Mexican health systems are changing to meet the needs of U.S. patients shared by the director general of a major private Mexican hospital.  Finally, the session will examine the legal and regulatory considerations around structuring and implementing medical tourism programs.

Educational Objectives:
• Explore the trends in the U.S. health care market that are driving the growing number of patients willing to seek medical care in other countries.
• Hear the results of new research on consumer attitudes toward medical tourism – and find out how ready Americans are to receive care beyond their own borders.
• Understand how medical tourism works, including the facts around growth, capacity, savings and quality – and a look at some of the current approaches in place at major employers and insurers.
• Discover why Mexico is an extremely attractive destination for patients and insurers – and gain a firsthand perspective from the director general of a major private Mexican hospital on changes underway in Mexican health systems to meet the requirements of American consumers.
• Examine the legal challenges around medical tourism on a full range of issues – from marketing restrictions to HIPAA to liability – and learn how to mitigate risks in structuring and executing programs.

Who would benefit most from attending this program?
In-house and outside counsel for employers, insurers and providers; human resource and benefit management executives; senior leadership from companies exploring new ways to reduce health care costs.


Jon Glaudemans, Managing Director, Manatt Health Solutions

Mr. Jon Glaudemans is a managing director of Manatt Health Solutions, an interdisciplinary policy and business advisory practice of Manatt, Phelps & Phillips, LLP.  Mr. Glaudemans has more than 30 years of senior leadership experience in health care operations, policy issues management, financial analysis, communications and health insurance.  His areas of focus include insurance regulation, payer-provider market dynamics, provider payment policy, e-health, health plan administration, health disparities and quality improvement initiatives across a variety of care settings.

Prior to joining Manatt, Mr. Glaudemans was Chief Advocacy Communications Officer at Ascension Health, the nation’s largest nonprofit healthcare system, with over 120 hospitals in more than 20 states.  He spent five years as the Senior Vice President/Chief Operating Officer at Avalere Health, LLC, a Washington-based advisory group.  In 2001, Mr. Glaudemans was asked to serve as Co-Transition Coordinator for the incoming Administrator for the Centers for Medicare and Medicaid Services, where he played a leadership role in designing and initiating the first federally sponsored prescription drug discount program.  He spent at decade at Aetna, where his roles included General Manager of Aetna U.S. Healthcare’s Mid-Atlantic Region.  Mr. Glaudemans began his career at the U.S. Office of Management and Budget (OMB), where he was intimately involved in Medicare budget, regulatory and legislative initiatives.

Mr. Glaudemans earned his M.P.A. from the Princeton University Woodrow Wilson School and his B.S. from the Massachusetts Institute of Technology.

Andrew Rudman, Managing Director, ManattJones Global Strategies

Mr. Andrew Rudman is a Managing Director with ManattJones Global Strategies.  Based in the firm’s Washington, D.C. office, Mr. Rudman leads ManattJones’ health care practice and counsels clients in the pharmaceutical, medical device and nutritional supplement sectors on regulatory and public policy challenges related to market entry and market access in the Americas.  He writes and speaks on Mexican health care issues, including systemic reform and public-private sector collaboration.  Mr. Rudman has experience in public policy and advocacy on behalf of the private sector and has worked extensively in Latin America as well as Canada and Russia.  Mr. Rudman has represented the biopharmaceutical industry before various domestic and foreign government entities and regulators, interest groups and academia and has successfully coordinated major trade and foreign policy initiatives.  As a former Foreign Service Officer and senior member of the Department of Commerce’s International Trade Administration, he has also advocated for U.S. companies in foreign markets.

Prior to joining the firm, Mr. Rudman was the Deputy Vice President for the Western Hemisphere of Pharmaceutical Research and Manufacturers of America (PhRMA).  Prior to joining PhRMA, Mr. Rudman was Director of the Office of NAFTA and Inter-American Affairs at the U.S. Department of Commerce.  He began his government career as a Foreign Service Officer in the U.S. Department of State.

Mr. Rudman earned his M.A. from Tulane University and his B.A., cum laude, from Colby College.

Linda Tiano, Partner, Healthcare Industry, Manatt, Phelps & Phillips, LLP

Ms. Linda Tiano has more than 30 years of health law experience.  Her practice focuses on providing regulatory and transactional guidance to health care providers, primarily in the managed care segment.  Her clients include health insurance companies; managed care plans, including Medicare, Medicaid and commercial health plans; health plan co-ops; health care providers, including hospitals and large physician organizations; and third-party vendors, including specialty networks and care management firms.

Ms. Tiano advises clients on alignment initiatives between hospitals and health plans, including joint ventures and value-based payment arrangements and the establishment and operation of Accountable Care Organizations (ACOs) and Physician-Hospital Organizations (PHOs), as well as other types of networks; health reform implementation; governance issues; compliance programs and reviews relating to state and federal laws; and the regulatory and transactional aspects of mergers and acquisitions, joint ventures, strategic affiliations and other health care business arrangements. She also drafts and negotiates major contractual arrangements, including business process outsourcing, Integrated Delivery Systems, ACOs and innovative payment agreements. In addition, she counsels early-stage health-related investors on the terms, conditions and risks related to their investments.

Ms. Tiano joined Manatt from a major national law firm, where she was a member of the Healthcare and Life Sciences practice. Prior to her work at the law firm, she was an executive and general counsel of both nonprofit and public health insurance companies for almost 20 years.

Ms. Tiano is admitted to practice in the District of Columbia and New York, before the New York Supreme Court, and federal courts in the Southern and Northern Districts of New York.  Ms. Tiano earned her J.D., cum laude, from Boston University School of Law and her B.A., summa cum laude, from University of Cincinnati.

Alfonso Vargas Rodriguez, Medical Director, Hospitals H+

Dr. Alfonso Vargas Rodriguez, MD, has been a member of the Executive Team of H+ since 2012, initially as head of Medical Liaison and then as Chief Medical and Operations Officer.  Prior to joining H+, Dr. Vargas worked in Medica Sur SAB de CV, the only hospital in Mexico listed in the Mexican Stock Exchange.  At Medica Sur, he worked as Chief Medical Officer and Chief Executive Officer of Clinica Medica Sur, a subsidiary within Medica Sur.  His most recent position was as Chief Communication Officers, where he was responsible for the Medical Credentials Committee.  Dr. Vargas studied Medicine at the Universidad La Salle and is Board Certified in Internal Medicine with a sub-specialization in Rheumatology.  In addition, he has a diploma in Hospital Administration and Finance from UNAM.